Clinical trial · Interventional
Food as Medicine: An RCT to Study the Effect of Home Delivered, Medically Tailored Meals on Patients With Metastatic Cancer
Food as Medicine: A Phase III Randomized Controlled Trial of Home Delivered, Medically Tailored Meals (HDMTM) on Quality of Life in Metastatic Lung and Non-colorectal GI Cancer Patients
NCT02887235CI-TRIAL-00045444completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine whether medically tailored meals (HDTM) can improve quality of life for patients with metastatic cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Home Delivered, Medically Tailored Meals (HDTM) | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Standard of Care (SOC) Meals
- description
- Patient assigned in this arm will receive standard of care nutritional services including nutrition consult, evaluation, and as needed follow-ups.
- type
- ACTIVE_COMPARATOR
- label
- Medically tailored meals
- description
- Patient assigned in this arm will receive home delivered, medically tailored meals (HDMTM) in addition to the standard nutritional care.
- interventionNames
- Other: Home Delivered, Medically Tailored Meals (HDTM)
Primary outcomes (1)
- measure
- Quality of life measurement
- timeFrame
- At 12 weeks follow up
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of pathologically confirmed metastatic pancreatic, hepatobiliary, esophageal, or lung cancer, either newly metastatic or metastatic at presentation (M1+) and enrollment within 6 weeks of diagnosis; measurable disease need not be present. * Pain Score (PS) 0-3 * Age\>18 * Both male and female subjects eligible * All ethnicities eligible * Access to refrigerator or freezer Exclusion Criteria: * Diagnosis of metastatic cancer no greater than 6 weeks prior to expected study enrollment * Currently receiving home delivered meals from other sources * Evidence of any alimentary tract obstruction or other condition preventing oral alimentation * Requirement for enteral or parenteral nutrition at time of diagnosis * Incarcerated individuals
References
Publications (0)
Data not yet available
No reference posted for this study.